We’re focused on three goals: transforming knowledge into medicines that make a difference for patients, creating value that will inspire the continued support of our fellow shareholders, and building a team that passionately pursues excellence.

Publications show all

Ironwood Pharmaceuticals has published 38 articles.

Patents show all

316Applications104Issued

Clinical Trials show all

17Phase 29Phase 33Phase 12N/A2Phase 4

SEC Filings show all

8-K8010-Q2110-K8D6S-11

Private Funding Events

DateOfferedSoldType
2013-01-10$175,000,000$175,000,000Debt
2009-11-17$15,000,018$15,000,018Equity
2009-09-03$24,999,996$24,999,996Equity
2009-09-03$249,996$249,996Equity
2008-09-26UnknownUnknownOther (Paper Filing)

Contact Information

    Key Executives

    • David Ebersman
      Director
    • Peter M. Hecht
      Executive Officer, Director
    • Michael J. Higgins
      Executive Officer
    • Joseph C. Cook, Jr.
      Director
    • Stephen Knight
      Director
    • Terrance G. Mcguire
      Director
    • Gina Bornino Miller
      Director
    • Bryan E. Roberts
      Director
    • Christopher T. Walsh
      Director
    • David Shaw
      Director
    • George H. Conrades
      Director
    • Mark G. Currie
      Executive Officer
    • Marsha Fanucci
      Director
    • Thomas Mccourt
      Executive Officer
    • David A. Ebersman
      Director
    • Marsha H. Fanucci
      Director
    • David E. Shaw
      Director